Skip to main content

Week One Progress

Figure 1: Diagram of preliminary design
The culmination of the hydrogel modulation design will yield a hydrogel wound dressing utilized for the therapeutic treatment of first-degree and second-degree exterior burns. A physical prototype of the hydrogel wound dressing will be produced by precipitating food-grade sodium alginate in a calcium chloride solution. The reaction yields spheres of low-density gel surrounded by a thin gelatinous membrane. The construction of an alginate dressing necessitates ionic cross-linking of the alginate solution with calcium ions, as to form the gel component. Both the high-density and low-density hydrogel layers will be generated in unison, before undergoing the freeze-drying process as to produce porous sheets. The physical prototype will be accompanied by a computer generated model of the hydrogel wound dressing, as evidenced in figure 1. The required components to construct the hydrogel adhesive were determined and subsequently purchased. The required components for the construction of the hydrogel adhesive, include: glassware, pipettes, sodium alginate, calcium chloride solution, FITC-BSA, spectrophotometer, and modeling tools. Moreover, food coloring will be required to dye the layers of hydrogel in different colors. Thus, the visible separation of hydrogel layers will determine whether the layers will transgress beyond the delineated boundaries. The construction of the tangible hydrogel adhesive prototype is expected to be completed within nine-weeks.





Comments

Popular posts from this blog

Week Five Progress

During week five, more research was done and the group was able to decide on the exact concentrations of calcium chloride to use in making each hydrogel layer as well as in the beads. The higher the concentration of calcium chloride, the more dense the hydrogel layer will be. Thus, for the thin, low-density layer, as well as for the low-density beads, a 5% calcium chloride solution will be used. For the thick, high-density layer, a 7% calcium chloride solution will be used. Refer to Figure 1, below, for a visual of the design. Figure 1: Preliminary Diagram of the Hydrogel Wound Dressing   Another task that was completed this week was additional planning for the testing phase. Once the hydrogel has been constructed, samples of it will be placed into cuvettes, and fluorescently-labeled bovine serum albumin (FITC-BSA) will be injected into the cuvettes, one at a time, in intervals of four hours. This will occur over a period of two days, and at the end of the two day...

Week Three Progress

During Week Three, we discussed and determined our therapeutic agent for the hydrogel module. After extensive research and comparison of our options, we decided the best-suited therapeutic would be zinc oxide. This substance fits our design so well because it is hydrophobic and will slowly disperse through the pores in the bottom hydrogel layer. Zinc oxide has been used in past hydrogel models and has been proven to be effective. It is an agent that has been used in ointments and supplements to treat burns and prevent infections. Likewise, the possibility of overdosing on zinc-oxide necessitates a solution for controlled therapeutic release. The predominant delivery system for zinc oxide is through medicinal cream, the delivery through which enables the therapeutic threshold of zinc oxide to be increased to levels of high toxicity. Symptoms of zinc-oxide overdose include: fever, chills, vomiting, mouth irritation, stomach pain, and yellowing of the eyes and skin. Consequently, the phar...

Week Four Progress

Our focus this week was finding the correct placebo for our design. Prior to this week, we had expected to use zinc oxide in our module but we realized it did not have a high enough molecular weight. Therefore, the zinc oxide would disperse from the hydrogel beads too rapidly. After some research and guidance from our professor, we decided to use Fluorescein Isothiocyanate-Bovine Serum Album (FITC-BSA), which is a hydrophilic protein with a molecular weight of 66 kg/mol [1]. FITC-BSA will also be our signal source for measuring the rate of dispersion from the beads. As seen in Figure 1, FITC-BSA is vivid in color and allows the protein's diffusion throughout the hydrogel to be observed easily. We've decided to initially use 0.25 mg/ml as the concentration of FITC-BSA within our design. Figure 1: FITC-BSA (green) seen in samples of HeLa cells [2] References: [1]  Bovine Serum Albumin Conjugates Product Information , 1st ed. Molecular Probes, 2005. [2] S. Sarker, R....